arrow
F

Filippo Alongi

University of Brescia
H指数:51
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Daily adaptive 1.5 T MR-Linac image-guided re-irradiation for prostate cancer: an international retrospective experience

每日适应性1.5 T MR-Linac图像引导再程放疗治疗前列腺癌:一项国际回顾性经验

2026-09-110
OAAI
Whole-pelvic Versus Prostate-only Radiotherapy in Clinically Node-negative High-Risk Localised Prostate Cancer: A Systematic Review and Meta-analysis with Reconstructed Individual-patient Data

临床N0期局部高危前列腺癌全盆腔与前列腺单放治疗的系统评价与基于重建个体患者数据的Meta分析

2026-09-010
PRE
Early outcomes of online adaptive MR-guided SBRT for localized prostate cancer: a prospective study

局部前列腺癌在线自适应MR引导SBRT的早期结果:一项前瞻性研究

2026-07-010
PRE
Daily adaptive radiotherapy in postoperative hypofractionated salvage radiothERapy for prostate cancer patients (DART-PHASER): Early clinical and dosimetric results

前列腺癌患者术后挽救性低分割放疗中的每日适应性放疗(DART-PHASER):早期临床和剂量学结果

2026-07-010
PRE
Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation Therapy

前列腺特异性抗原谷值及达到谷值时间可预测未接受雄激素剥夺治疗的挽救性放疗术后患者复发

2025-12-150
OAAI
ESTRO-ISRS clinical practice recommendations for re-irradiation of spinal mestastases with Stereotactic body radiotherapy: delphi consensus supported by a systematic review and meta-analysis

ESTRO-ISRS关于脊柱转移瘤立体定向体部放射治疗再程放疗的临床实践指南:基于系统评价和Meta分析的德尔菲共识支持

2025-12-020
OAAI
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial

BRCA在阿比特龙±立体定向体部放射治疗接受者的影响:ARTO试验

2025-12-010
PRE
Predictive Value of PSA Bounce Phenomenon after Stereotactic Body Radiation Therapy in a Large Population of Prostate Cancer Patients Treated By 1.5 T MR Guided Adaptive Technique

前列腺癌患者经1.5 T MRI引导自适应技术治疗后,立体定向体部放射治疗中PSA反弹现象的预测价值

2025-11-010
OA
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study

惩罚生存诺模图预测前列腺癌根治术后患者挽救性放疗后的5年无转移生存率:一项多中心研究

2025-11-010
OA
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START)

对受前列腺癌影响并在接受前期根治性或术后放射治疗后复发的患者进行再放射治疗。一项由意大利放射治疗与临床肿瘤学协会(AIRO)代表开展的国际注册研究(RE-START)。

2025-09-130
PRE
Oligometastatic Mesothelioma Treated with Ablative Radiotherapy (OMAR): A Multicenter Study

寡转移性间皮瘤经消融放疗治疗(OMAR):一项多中心研究

2025-08-270
OA
Salvage Radiotherapy Following Nonradiotherapy Ablative Techniques for Primary Prostate Cancer: A Systematic Review and Meta-analysis

非放疗消融技术后用于原发性前列腺癌的挽救性放射治疗:一项系统评价和Meta分析

2025-04-100
OAAI
Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy

生活质量与毒性反应:接受在线自适应立体定向磁共振引导放射治疗的胰腺导管腺癌患者

2025-04-020
PRE
RT for the management of locally advanced rectal cancer: Don't throw the baby with the bath water!
2025-04-010
PRE
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est)

下一代成像在前列腺癌管理中不断扩展的作用:一项探索意大利东北部泌尿肿瘤学家临床实践的横断面调查;代表GUONE(Gruppo Uro-Oncologico del Nord-Est)

2025-03-120
OA